Entero Therapeutics, Inc. (ENTO)

Entero Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	0.06	0.16	3.71	1.36	8.25	6.06
Cash & Short-Term Investments	0.06	0.16	3.71	1.36	8.25	6.06
Cash Growth	-98.27%	-95.60%	172.34%	-83.48%	36.07%	3348.39%
Other Receivables	-	-	-	0.09	-	0.55
Receivables	-	-	-	0.09	-	0.55
Prepaid Expenses	0.23	0.15	1.24	1.96	1.18	1.26
Other Current Assets	83.17	83.17	-	-	-	-
Total Current Assets	83.46	83.48	4.96	3.41	9.42	7.87
Property, Plant & Equipment	-	0.13	0.21	0.3	0.41	0.09
Goodwill	1.68	1.68	1.68	1.68	1.91	2.05
Other Intangible Assets	-	-	-	-	-	2.88
Other Long-Term Assets	0.06	0.12	0.03	0.04	0.04	0.03
Total Assets	85.2	85.41	6.88	5.44	11.79	12.92
Accounts Payable	2.85	2.96	0.55	0.72	2.71	1.56
Accrued Expenses	0.3	0.25	0.83	0.32	0.39	0.13
Short-Term Debt	0.7	-	0.61	0.6	0.64	0.55
Current Portion of Leases	0.14	0.08	0.07	0.07	0.08	0.06
Other Current Liabilities	24.75	24.25	1.07	0.77	8.48	13.25
Total Current Liabilities	28.74	27.55	3.13	2.48	12.3	15.55
Long-Term Leases	-	0.06	0.15	0.21	0.31	0.02
Other Long-Term Liabilities	-	-	-	-	7	-
Total Liabilities	28.74	27.61	3.28	2.7	19.61	15.56
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	198.43	198.51	187.93	171.28	147.31	93.84
Retained Earnings	-203.65	-202.39	-184.33	-168.53	-153.9	-95.37
Comprehensive Income & Other	-	-	-	-	-1.22	-1.11
Total Common Equity	-5.22	-3.88	3.6	2.74	-7.82	-2.64
Shareholders' Equity	56.46	57.8	3.6	2.74	-7.82	-2.64
Total Liabilities & Equity	85.2	85.41	6.88	5.44	11.79	12.92
Total Debt	0.84	0.14	0.83	0.88	1.03	0.63
Net Cash (Debt)	-0.78	0.02	2.88	0.48	7.22	5.43
Net Cash Growth	-	-99.20%	502.02%	-93.36%	32.86%	-
Net Cash Per Share	-0.19	0.01	8.58	13.34	-	-
Filing Date Shares Outstanding	4.77	4.77	2.03	0.08	-	-
Total Common Shares Outstanding	4.77	4.75	1.56	0.05	-	-
Working Capital	54.72	55.93	1.82	0.93	-2.88	-7.68
Book Value Per Share	-1.09	-0.82	2.31	55.12	-	-
Tangible Book Value	-6.9	-5.56	1.92	1.06	-9.73	-7.57
Tangible Book Value Per Share	-1.45	-1.17	1.23	21.27	-	-
Machinery	-	0.06	0.06	0.06	0.06	0.03
Leasehold Improvements	-	0.03	0.03	0.03	0.03	0.03

Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q